Michael E Ohl
Overview
Explore the profile of Michael E Ohl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ohl M, Carrell M, Thurman A, Vander Weg M, Hudson T, Mengeling M, et al.
BMC Health Serv Res
. 2020 Dec;
20(1):1147.
PMID: 33349262
No abstract available.
12.
Howren M, Francis S, Polgreen L, Shafer C, Hoth A, Ohl M
Public Health Rep
. 2020 Oct;
136(2):172-182.
PMID: 33108986
Objective: Preexposure prophylaxis (PrEP) is a safe and effective method for HIV prevention, but little is known about PrEP uptake in rural and small urban areas. We described rates and...
13.
Kobayashi T, Beck B, Miller A, Polgreen P, OShea A, Ohl M
Open Forum Infect Dis
. 2020 Jul;
7(6):ofaa201.
PMID: 32607386
Background: Prior studies have used (ICD) diagnosis codes in administrative data to identify patients with infective endocarditis (IE) associated with intravenous drug use (IVDU). Little is known about the accuracy...
14.
Goto M, Jones M, Schweizer M, Livorsi D, Perencevich E, Richardson K, et al.
JAMA Netw Open
. 2020 Feb;
3(2):e1921048.
PMID: 32049296
Importance: Staphylococcus aureus bacteremia (SAB) is common and associated with poor long-term outcomes. Previous studies have demonstrated an association between infectious diseases (ID) consultation and improved short-term (ie, within 90...
15.
Van Epps P, Wilson B, Garner W, Beste L, Maier M, Ohl M
J Acquir Immune Defic Syndr
. 2019 Nov;
82(5):427-430.
PMID: 31714421
Background: Cases of HIV, while infrequent, have been reported during tenofovir disoproxil fumarate/emtricitabine use as pre-exposure prophylaxis (PrEP). We describe the incidence of HIV and patterns of PrEP use within...
16.
Hoth A, Shafer C, Dillon D, Mayer R, Walton G, Ohl M
Sex Transm Dis
. 2019 Jul;
46(8):507-512.
PMID: 31295217
Background: Access to human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) is often poor in small urban and rural areas because of stigma and long distances to providers. The Iowa Department...
17.
Ohl M, Richardson K, Rodriguez-Barradas M, Bedimo R, Marconi V, Morano J, et al.
Open Forum Infect Dis
. 2019 Jun;
6(6):ofz206.
PMID: 31211155
Background: Telehealth may improve care for people with HIV who live far from HIV specialty clinics. We conducted a cluster-randomized evaluation to determine the impact of availability of HIV telehealth...
18.
Lund B, Ohl M, Hadlandsmyth K, Mosher H
Mil Med
. 2019 May;
184(11-12):894-900.
PMID: 31111908
Introduction: Opioid prescribing is heterogenous across the US, where 3- to 5-fold variation has been observed across states or other geographical units. Residents of rural areas appear to be at...
19.
Javier S, Troszak L, Shimada S, McInnes D, Ohl M, Avoundjian T, et al.
J Am Med Inform Assoc
. 2019 Mar;
26(8-9):696-702.
PMID: 30924875
Objective: To examine sociodemographic characteristics associated with use of My HealtheVet (MHV) by veterans living with HIV. Materials And Methods: Veterans Health Administration administrative data were used to identify a...
20.
Garner W, Wilson B, Beste L, Maier M, Ohl M, Van Epps P
Am J Public Health
. 2018 Nov;
108(S4):S305-S310.
PMID: 30383417
Objectives: To report demographics, regional variations, and indications for preexposure prophylaxis (PrEP) use for HIV prevention in the Veterans Health Administration (VHA). Methods: We identified persons initiating tenofovir/emtricitabine for the...